• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECKMAN COULTER ACCUTNI+3; IMMUNOASSAY METHOD, TROPONIN SUBUNIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECKMAN COULTER ACCUTNI+3; IMMUNOASSAY METHOD, TROPONIN SUBUNIT Back to Search Results
Model Number A98264
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 05/02/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The full patient identifier is (b)(4).The customer did not supply patient demographics such as age, date of birth, sex, weight, ethnicity or race.The access accutni+3 reagent was not returned for evaluation.A beckman coulter field service engineer (fse) was dispatched to assess system performance.Fse performed precision study, system check, high sensitivity system check and carryover test, all of which returned acceptable results indicating the system is performing within specifications.Fse noted the customer was using non-gel lithium heparin tubes.Fse noted centrifuge was functioning properly but there was a buffer of lightly mixed cells between plasma and red blood cell (rbc) layer.Customer stated that occasionally the centrifuge would leave rbc trails along the side of the tube during processing.Fse advised customer to make aliquots, and check sample integrity, prior to testing.In conclusion, although sample handling may have contributed to the event, the cause of the event cannot be determined with the available information.
 
Event or Problem Description
On 04may2022 the customer reported that on (b)(6) 2022, an erroneous non-reproducible elevated troponin i (access accutni+3, part number a98264 and lot number 125664) was generated for one patient on the customer's dxi (dxi 600 access immunoassay analyzer w/spot b, part number a71460 and serial number (sn) (b)(4).The result of 0.07 ng/ml was reported out of the laboratory.There was a report of change to patient treatment or management in connection with the event.The customer reported that the patient was sent for an angiogram.No further information regarding patient treatment or outcome was provided.Patient was redrawn and sample was run on customer's other dxi (dxi 600 access immunoassay analyzer w/spot b, part number a71460 and sn (b)(4) and result of 0.00 ng/ml was obtained.The original sample was then retested on dxi sn (b)(4) and a result of 0.01 ng/ml was obtained.The original sample was then tested on dxi sn (b)(4) and a result of 0.03 ng/ml was obtained.The second sample was also tested in duplicate on dxi sn (b)(4) and results of 0.01 ng/ml and 0.00 g/ml were obtained.System performance indicators such as calibration and quality control (qc) were passing within specifications at the time of the event.No hardware errors or other assay issues were reported in conjunction with the event.No other patient sample results were questioned.Samples were collected in non-gel lithium heparin tubes and centrifuged at 3600rpms for 10 minutes.Samples were noted to be clear.Samples were tested from original sample tubes and not recentrifuged prior to retesting.No other sample handling information was provided.A beckman coulter field service engineer (fse) was dispatched to assess system performance.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCUTNI+3
Common Device Name
IMMUNOASSAY METHOD, TROPONIN SUBUNIT
Manufacturer (Section D)
BECKMAN COULTER
1000 lake hazeltine drive
chaska MN 55318
Manufacturer (Section G)
BECKMAN COULTER
1000 lake hazeltine drive
chaska MN 55318
Manufacturer Contact
angela vettel
250 s. kraemer blvd.
brea, CA 92821
7149613625
MDR Report Key14402629
Report Number2122870-2022-00023
Device Sequence Number17505804
Product Code MMI
UDI-Device Identifier15099590209353
UDI-Public(01)15099590209353(17)221231(11)211231(10)125664
Combination Product (Y/N)N
Initial Reporter StateVA
Initial Reporter CountryUS
PMA/510(K) Number
K121790
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 05/13/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date12/31/2022
Device Model NumberA98264
Device Catalogue NumberA98264
Device Lot Number125664
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/04/2022
Initial Report FDA Received Date05/13/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured12/31/2021
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-